Zhengshan Chen

4.4k citations
70 papers · 1.4k indexed · h-index 20

Zhengshan Chen

65 papers receiving 1.3k citations

Peers

Zhengshan Chen
Comparison fields: 5 of 115
  • Immunology 496
  • Hematology 131
  • Radiology, Nuclear Medicine and Imaging 256
  • Cancer Research 150
  • Molecular Biology 660
Replace Weiping Zeng with:
Weiping Zeng United States
Doris Vokurková Czechia
Shai Cohen Israel
James J. O’Leary United States
Wenjuan Yang China
Yan Jia China
Deepak Kaul India
Davoud Rostamzadeh Iran
Runqing Lu United States
Catriona McKenzie Australia
Zhengshan Chen relative to Weiping Zeng United States Weiping Zeng's profile →
Citations per field
00.5×1.6×
Weiping Zeng · 1×
Citations per year

Countries citing papers authored by Zhengshan Chen

Since Specialization
Citations

This map shows the geographic impact of Zhengshan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengshan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengshan Chen more than expected).

Fields of papers citing papers by Zhengshan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengshan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengshan Chen. The network helps show where Zhengshan Chen may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Zhengshan Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zhengshan Chen Line = papers co-authored together Zhengshan Chen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20240
4 20241
5 20230
6 20236
7 20238
8 20226
9 20222
10 20217
11 202017
12 20207
13 20199
14 201891
15 201830
16 201418
17
Requirement and Application Preliminary Study of the Emergency Communication of the Destructive Earthquakes
20121
18 201252
19 201120
20 201052

About Zhengshan Chen

Zhengshan Chen is a scholar working on Hematology, Immunology and Geochemistry and Petrology, having authored 70 papers that have together received 1.4k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (12 papers), Glycosylation and Glycoproteins Research (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Immune Cell Function and Interaction (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (5 papers), T-cell and Retrovirus Studies (4 papers) and Viral Infections and Vectors (4 papers). The work is most often cited by research in Immunology (496 citations), Hematology (131 citations) and Radiology, Nuclear Medicine and Imaging (256 citations). Zhengshan Chen has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jiang Gu, Christine Korteweg, Hilde Schjerven, Ignacio A. Demarco, Karen L. Reddy, Damien Reynaud, Stephen T. Smale, Susan Winandy, Eric Bertolino and Harinder Singh. Their work appears in journals such as Cell, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026